Literature DB >> 18305885

Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study.

G Zhai1, D J Hart, A M Valdes, B S Kato, J B Richards, A Hakim, T D Spector.   

Abstract

UNLABELLED: In this 15-year follow-up study, we found that the estimated rate of bone loss at the femoral neck (FN) for women aged 45-68 was linear at a rate of 1.67% per year, but quadratic for lumbar spine (LS) at a rate of 3.12% initially, and slowing down with age. We also confirmed the protective role of HRT, increasing weight, and lean mass in long-term bone loss.
INTRODUCTION: The objective was to describe the natural history of bone loss and explore the role of environmental factors in postmenopausal women over a 15-year period.
METHODS: Bone mineral density (BMD) at the FN and the LS were measured in postmenopausal women from the Chingford Study. Height, weight, HRT status, and calcium/vitamin D supplement were assessed at each visit. Osteoarthritis of hip and spine was assessed by X-ray at baseline and at year 8.
RESULTS: A total of 955 postmenopausal women with an average age of 54.7 at baseline were included. Both FN and LS BMD decreased significantly with age (p<0.0001). The decline was larger in the LS (-3.12% per year), which showed a quadratic relationship, than in the FN (-1.67% per year) with a linear relationship. The rate of bone loss was reduced by one third annually for the FN and LS respectively in current HRT users. Change in weight was positively associated with both DeltaFN and DeltaLS BMD (beta=0.16% and 0.09% change in DeltaFN and DeltaLS BMD per kilogramme change in weight respectively, p<0.0001 for both sites). Spine OA and progression were positively associated with DeltaLS BMD (beta=1.22% change in DeltaLS BMD per grade in spine OA and 0.45% change in DeltaLS BMD for patients who progressed, p<0.0001 for spine OA and p=0.002 for spine OA progression). Spine OA (beta=0.54% change in DeltaFN BMD per grade, p<0.0001), but not progression, and hip OA were positively associated with DeltaFN BMD. Furthermore, both age and body weight at baseline were positively associated with both DeltaFN and DeltaLS BMD (beta=0.02-0.04% change in DeltaFN and DeltaLS BMD per year increase in age at baseline and 0.004-0.007% change in DeltaFN and DeltaLS BMD per kilogramme increase in weight at baseline, all p<0.0001).
CONCLUSION: This large population-based longitudinal study demonstrated that the decline of BMD over 15 years is linear with age for the FN, but quadratic for the LS. The study confirmed the protective role of HRT, increased weight and lean mass in long-term bone loss.

Entities:  

Mesh:

Year:  2008        PMID: 18305885     DOI: 10.1007/s00198-008-0562-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  23 in total

1.  SequenceLDhot: detecting recombination hotspots.

Authors:  Paul Fearnhead
Journal:  Bioinformatics       Date:  2006-10-23       Impact factor: 6.937

2.  A prospective study of bone loss in menopausal Australian-born women.

Authors:  J R Guthrie; P R Ebeling; J L Hopper; E Barrett-Connor; L Dennerstein; E C Dudley; H G Burger; J D Wark
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

3.  A meta-analysis of the effects of cigarette smoking on bone mineral density.

Authors:  K D Ward; R C Klesges
Journal:  Calcif Tissue Int       Date:  2001-05       Impact factor: 4.333

Review 4.  Sarcopenia: current concepts.

Authors:  R Roubenoff; V A Hughes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-12       Impact factor: 6.053

5.  Smoking and fracture risk: a meta-analysis.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; C De Laet; J A Eisman; S Fujiwara; H Kroger; E V McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

6.  Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.

Authors:  A Shiraishi; M Ito; N Hayakawa; N Kubota; N Kubodera; E Ogata
Journal:  Calcif Tissue Int       Date:  2006-03-08       Impact factor: 4.333

Review 7.  The effect of obesity on postmenopausal bone loss and the risk of osteoporosis.

Authors:  C Ribot; F Trémollières; J M Pouillès
Journal:  Adv Nutr Res       Date:  1994

8.  Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis.

Authors:  T Masud; S Langley; P Wiltshire; D V Doyle; T D Spector
Journal:  BMJ       Date:  1993-07-17

9.  The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study.

Authors:  D J Hart; T D Spector
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

10.  Cigarette smoking and risk of osteoarthritis in women in the general population: the Chingford study.

Authors:  D J Hart; T D Spector
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

View more
  21 in total

1.  Baseline age and time to major fracture in younger postmenopausal women.

Authors:  Margaret Lee Gourlay; Robert A Overman; Jason P Fine; Kristine E Ensrud; Carolyn J Crandall; Margery L Gass; John Robbins; Karen C Johnson; Erin S LeBlanc; Catherine R Womack; John T Schousboe; Andrea Z LaCroix
Journal:  Menopause       Date:  2015-06       Impact factor: 2.953

2.  Long-Term and Recent Weight Change Are Associated With Reduced Peripheral Bone Density, Deficits in Bone Microarchitecture, and Decreased Bone Strength: The Framingham Osteoporosis Study.

Authors:  Ching-Ti Liu; Shivani Sahni; Hanfei Xu; Robert R McLean; Kerry E Broe; Marian T Hannan; Steven K Boyd; Mary L Bouxsein; Douglas P Kiel; Elizabeth J Samelson
Journal:  J Bone Miner Res       Date:  2018-06-15       Impact factor: 6.741

3.  Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women.

Authors:  M L Gourlay; J S Preisser; C A Hammett-Stabler; J B Renner; J Rubin
Journal:  Osteoporos Int       Date:  2010-12-02       Impact factor: 4.507

4.  PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly.

Authors:  A Arabi; R Baddoura; R El-Rassi; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2011-06-08       Impact factor: 4.507

5.  Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women.

Authors:  Margaret L Gourlay; Bonny L Specker; Chenxi Li; Catherine A Hammett-Stabler; Jordan B Renner; Janet E Rubin
Journal:  Bone       Date:  2011-11-07       Impact factor: 4.398

6.  Genetic and environmental determinants on bone loss in postmenopausal Caucasian women: a 14-year longitudinal twin study.

Authors:  G Zhai; T Andrew; B S Kato; G M Blake; T D Spector
Journal:  Osteoporos Int       Date:  2008-09-23       Impact factor: 4.507

7.  Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study.

Authors:  Gregory Livshits; Guangju Zhai; Deborah J Hart; Bernet S Kato; Huizhong Wang; Frances M K Williams; Tim D Spector
Journal:  Arthritis Rheum       Date:  2009-07

8.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Oscar L Lopez; Paula Diehr; Ellen S O'Meara; W T Longstreth; José A Luchsinger
Journal:  Arch Neurol       Date:  2009-03

9.  Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors.

Authors:  Délio Marques Conde; Lúcia Costa-Paiva; Edson Zangiacomi Martinez; Aarão Mendes Pinto-Neto
Journal:  Breast Care (Basel)       Date:  2012-04-23       Impact factor: 2.860

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.